Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• A completed paradigm shift for VADS in advanced HF: The INTERMACS registry at 5 years James B. Young, MD
• ABSORB: Second generation bioresorbable stent demonstrates improvement
• APPOSITION II: Self-expanding stent reduces malapposition by factor of 10
• Black and Hispanic patients with chest pain often downgraded in ER
• Burnout linked to unprofessional behavior, less altruism among medical students
• CARISMA: Implantable cardiac monitor detected bradyarrhythmias, tachyarrhythmias in patients after acute MI
• Challenges with clopidogrel pave potential road for new agents
• Clamp procedure yields positive results in setting of significant mitral regurgitation
• CLOSURE I: Superiority not substantiated for PFO closure vs. anticoagulation therapies
• DANPACE: All-cause mortality in patients with sick sinus syndrome did not differ with AAIR, DDDR pacing
• Discrepancies found between physician and patient expectations of PCI
• Drug-eluting balloons data indicate therapeutic potential
• EVEREST II: Effectiveness of mitral valve debated, despite demonstrated safety
• FDA adds warning to gadolinium-based contrast agents
• FDA restricts rosiglitazone use
• FUTURA/OASIS-8: No reduction in PCI bleeding complications with low-dose heparin in patients treated with fondaparinux
• Genotypes linked with antiplatelet effect of clopidogrel
• Guideline changes for CPR led to higher neurologically-intact hospital discharge rates
• Higher doses of CD34+ cells may improve functional recovery from STEMI
• Incidental findings in routine CT scans can predict CVD
• Insulin resistance linked with increased risk for stroke in patients without diabetes
• LEADERS: Biolimus-eluting stent potentially beneficial in patients with STEMI
• LEVANT I, PERFECT suggest promise for drug-eluting balloons
• LV geometry influential in DSMR-wall motion accuracy
• MADIT II follow-up: Survival benefit sustained out to 8 years
• Meta-analysis: Statins yield post-procedural MI benefit when administrated prior to invasive procedures
• Omega-3 PUFAs improved LV systolic, diastolic function in patients with nonischemic dilated cardiomyopathy
• PARTNER: TAVI in high-risk surgical patients linked with reduced mortality rates
• Patient history, preference determine successful use of new mitral valve
• PCI yields low event rates vs. CABG in patients with lower SYNTAX score
• Pneumococcal disease: A red flag in heart disease management
• Reduced in-hospital mortality reported in patients undergoing endovascular repair for TBAD
• Stenting associated with increased risk for stroke, death in patients 70 years or older with symptomatic carotid stenosis
• Testosterone associated with improved functioning, muscle strength in elderly women with chronic HF
• Transfemoral access in transcatheter valve registries linked with lower 30-day mortality
• Universal definition of bleeding needed, researchers suggest
• Valve features advancements to clinically-proven design
• FDA clarifies safety data required in clinical trial reporting
• Bystander chest compression-only CPR linked with survival benefit for cardiac arrest
• Cardiomyocyte-specific microRNA presents diagnostic potential for CV disorders
• CMR detected key characteristics after right ventricular ischemic injury
• COGENT: PPI use reduced rate of gastrointestinal bleeding in patients given clopidogrel, aspirin
• Dyssynchrony indices not predictive of response to CRT
• End-of-life costs on the rise for patients with HF in U.S. and Canada
• Folic acid supplementation for homocysteine reduction yields no effect on vascular outcomes
• Follow-up SPECT myocardial perfusion imaging scans performed infrequently in patients without prior CAD
• High economic burden, rates of revascularization for patients with PAD
• Incidental findings prevalence varied by imaging modality and other factors
• Laser sheaths extracted old leads with similar success, shorter procedure times vs. femoral approach
• Occupational, leisure-time physical activity reduced risk for HF
• Periaortic fat linked with PAD, low ankle-brachial index
• Pine bark extract found ineffective for lowering CVD risk factors
• Severe hypoglycemia increased risk for major macrovascular, microvascular events
• Douglas L. Mann, MD, leader, scholar and innovator in HF therapeutics